Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 21 | Foote TimChief Financial Officer | Option exercise | M | — 34.9K sh | Jan 6, 2026 |
| 21 | Voskanian ShauntChief Revenue Officer | Open-market sale · 10b5-1 plan | SELL | $74K 1,997 sh | Jan 6, 2026 traded Jan 2, 2026 |
| 21 | Rodriguez Joseph RyanChief Risk and Legal Officer | Option exercise | M | — 5,112 sh | Jan 6, 2026 traded Jan 2, 2026 |
| 21 | Rodriguez Joseph RyanChief Risk and Legal Officer | Option exercise | M | — 4,982 sh | Jan 6, 2026 traded Jan 2, 2026 |
| 21 | Kosaraju SheelaSVP and General Counsel | Open-market sale · 10b5-1 plan | SELL | $421K 1,748 sh | Jan 6, 2026 traded Jan 2, 2026 |
| 21 | Durham MarkChief Accounting Officer | Grant or award | A | — 1,050 sh | Jan 6, 2026 traded Jan 2, 2026 |
| 21 | Huang Chieh E.Director | Grant or award | A | — 13.0K sh | Jan 6, 2026 traded Jan 2, 2026 |
| 21 | Sachs Alan BruceDirector | Grant or award | A | — 23.4K sh | Jan 6, 2026 traded Jan 2, 2026 |
| 21 | Voskanian ShauntChief Revenue Officer | Open-market sale · 10b5-1 plan | SELL | $83K 2,200 sh | Jan 6, 2026 traded Jan 5, 2026 |
| 21 | Lange John DDirector | Grant or award | A | — 1,603 sh | Jan 6, 2026 traded Jan 2, 2026 |
| 21 | Bragg David D.SVP - Chief Financial Officer | Grant or award | A | — 87.4K sh | Jan 6, 2026 traded Jan 2, 2026 |
| 21 | Herb TylerChief Accounting Officer | Open-market sale · 10b5-1 plan | SELL | $90K 2,440 sh | Jan 6, 2026 traded Jan 5, 2026 |
| 21 | Dutra FelipeDirector | Grant or award | A | — 13.0K sh | Jan 6, 2026 traded Jan 2, 2026 |
| 21 | Foote TimChief Financial Officer | Option exercise | M | — 34.9K sh | Jan 6, 2026 traded Jan 2, 2026 |
| 21 | Mulligan BrendanGeneral Counsel and Secretary | Open-market sale · 10b5-1 plan | SELL | $162K 4,366 sh | Jan 6, 2026 traded Jan 5, 2026 |
| 21 | Voskanian ShauntChief Revenue Officer | Open-market sale · 10b5-1 plan | SELL | $231K 6,249 sh | Jan 6, 2026 traded Jan 5, 2026 |
| 21 | Mulligan BrendanGeneral Counsel and Secretary | Open-market sale · 10b5-1 plan | SELL | $127K 3,449 sh | Jan 6, 2026 traded Jan 2, 2026 |
| 20 | Mumenthaler Christian StephaneDirector | Grant or award | A | $51K 639 sh | Jan 6, 2026 traded Jan 2, 2026 |
| 20 | Ribeiro RamiroChief Medical Officer | Tax withholding | F | $111K 6,373 sh | Jan 6, 2026 traded Jan 3, 2026 |
| 19 | Turvey Paul RobertSVP & Assoc. General Counsel | Tax withholding | F | $277K 5,548 sh | Jan 6, 2026 traded Jan 2, 2026 |
| 19 | Blevins ChristopherGeneral Counsel | Option exercise | M | — 12 sh | Jan 6, 2026 traded Jan 1, 2026 |
| 18 | Sahni Sanjeev SinghPresident | Open-market sale · 10b5-1 plan | SELL | $64K 941 sh | Jan 6, 2026 traded Jan 5, 2026 |
| 18 | Herb TylerChief Accounting Officer | Open-market sale · 10b5-1 plan | SELL | $45K 1,222 sh | Jan 6, 2026 traded Jan 2, 2026 |
| 18 | Bachrodt AmySVP, Finance | Open-market sale · 10b5-1 plan | SELL | $93K 2,405 sh | Jan 6, 2026 traded Jan 2, 2026 |
| 18 | Bachrodt AmySVP, Finance | Open-market sale · 10b5-1 plan | SELL | $103K 2,595 sh | Jan 6, 2026 traded Jan 2, 2026 |
| 18 | Sahni Sanjeev SinghPresident | Open-market sale · 10b5-1 plan | SELL | $189K 2,828 sh | Jan 6, 2026 traded Jan 5, 2026 |
| 18 | Herb TylerChief Accounting Officer | Open-market sale · 10b5-1 plan | SELL | $15K 400 sh | Jan 6, 2026 traded Jan 5, 2026 |
| 18 | Herb TylerChief Accounting Officer | Open-market sale · 10b5-1 plan | SELL | $45K 1,186 sh | Jan 6, 2026 traded Jan 2, 2026 |
| 18 | Mulligan BrendanGeneral Counsel and Secretary | Open-market sale · 10b5-1 plan | SELL | $49K 1,300 sh | Jan 6, 2026 traded Jan 5, 2026 |
| 17 | Moriarty Brian AndrewSVP - Corporate Communications | Grant or award | A | — 4,835 sh | Jan 6, 2026 traded Jan 2, 2026 |
| 17 | Ribeiro RamiroChief Medical Officer | Option exercise | M | — 19.7K sh | Jan 6, 2026 traded Jan 3, 2026 |
| 17 | Puwalski AllenDirector | Grant or award | A | — 15.9K sh | Jan 6, 2026 traded Jan 2, 2026 |
| 17 | Lovalekar TusharVP, Information Technology | Grant or award | A | — 368 sh | Jan 6, 2026 traded Jan 2, 2026 |
| 17 | Altamura Michelle VervaisEVP, General Counsel, Sec. | Option exercise | M | — 1,214 sh | Jan 6, 2026 traded Jan 2, 2026 |
| 17 | Gravier PierreCHIEF FINANCIAL OFFICER | Grant or award | A | — 20.0K sh | Jan 6, 2026 traded Jan 2, 2026 |
| 17 | Johnson Gwendolyn MarySVP - Asset Management | Grant or award | A | — 5,073 sh | Jan 6, 2026 traded Jan 2, 2026 |
| 17 | Roberts Malcolm JamesEVP & Chief Commercial Officer | Grant or award | A | — 8,148 sh | Jan 6, 2026 traded Jan 2, 2026 |
| 17 | Bowman Erica SVICE PRESIDENT | Option exercise | M | — 776 sh | Jan 6, 2026 traded Jan 2, 2026 |
| 17 | Mazzara PhilipGeneral Counsel and Secretary | Open-market sale · 10b5-1 plan | SELL | $411K 2,304 sh | Jan 6, 2026 traded Jan 2, 2026 |
| 17 | Guarini KathrynDirector | Grant or award | A | — 155 sh | Jan 6, 2026 traded Jan 2, 2026 |